CRL vs GRC · rev $2.00B vs P/E 23, rev $186.1M
Charles River Laboratories (CRL) versus Gorman-Rupp Company (GRC) — a side-by-side from cached financials, not a winner call.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
Gorman-Rupp Company (GRC) is a specialty industrial machinery company listed on US.
Latest reported CRL revenue for 2026-06-27 was $2.00B. Net income was -$16.3M. CRL currently screens at market cap $7.78B.
Latest reported GRC revenue for 2026-06-30 was $186.1M. Net income was $19.4M. Revenue was up 5.4% from 2026-03-31 to 2026-06-30. GRC currently screens at market cap $1.02B and trailing P/E 23.0.
CRL currently screens at market cap $7.78B. GRC currently screens at market cap $1.02B and trailing P/E 23.0.
Not investment advice. Open the CRL and GRC stock pages for the full models.
Not investment advice.